Colorectal carcinoma remains one of the primary contributors to cancer deaths; however, it is also considered a preventable type of cancer, because the prognosis of the disease is directly dependent on its timely detection. Developing accurate risk prediction models for colorectal cancer is crucial for identifying individuals at both low and high risk, as risk stratification determines the need for additional interventions, which carry their own risks. The development of new non-invasive diagnostic methods based on biomaterial analysis, alongside standard diagnostic techniques such as colonoscopy with biopsy, computed tomography scanning, and magnetic resonance imaging, can address multiple objectives: improving screening accuracy, providing a comprehensive assessment of minimal residual disease, identifying patients at a high risk of colorectal cancer, and evaluating the effectiveness of ongoing treatments. The lack of sensitive diagnostic methods drives contemporary research toward the discovery of new tools for detecting tumor cells, particularly through the examination of biological materials, including blood, exhaled air, and tumor tissue itself. In this article, we analyze current studies regarding biomarkers in colorectal cancer and prognostic significance.
Aim. To evaluate the early manifestation of cardiotoxicity after the first course of multiagent chemotherapy (MAC) using echocardiography with an assessment of the left ventricular ejection fraction (LVEF) and global longitudinal strain (GLS).Material and methods. The study included 49 cancer patients with elective MAC.Results. After the first administration of a therapeutic dose of chemotherapy, a decrease in LVEF ≥10 and GLS >15 was demonstrated in more than 6,1% of patients, as well as a subclinical decrease in LVEF ≥5% in 22,4% and a decrease in GLS ≥12% in 24,5%.Conclusion. In cancer patients, after the first course of chemotherapy, GLS dynamics should be assessed during echocardiography as a marker of myocardial dysfunction.
Background: Exhaled volatile organic compounds (VOCs) may provide a non-invasive readout of biological changes in colorectal cancer (CRC). We characterized early postoperative changes in the exhaled volatilome after curative CRC surgery and explored a multivariable VOC signature associated with clinical state. Methods: In this prospective paired pilot study, breath samples were obtained from 38 patients before surgery (Before) and on postoperative day 10 (After) and from 44 healthy controls (Control). Proton transfer reaction time-of-flight mass spectrometry (PTR-TOF-MS) identified 61 informative volatile organic compound (VOC) features. Elastic Net-based stability selection with 1000 patient-grouped resampling iterations yielded a 16-feature panel. Pairwise univariate comparisons were performed with Benjamini–Hochberg false discovery rate (FDR) correction. Results: Five selected VOC features differed significantly between paired preoperative and postoperative samples. Two features (mass-to-charge ratio [m/z] 77.0576 and 103.074) no longer differed significantly from healthy controls postoperatively, whereas three (m/z 63.0157, 95.0534, and 101.05) remained significantly different. The highest discriminative performance was observed for After vs. Control (median ROC AUC = 0.811 [95% PR, 0.691–0.912]), followed by Before vs. Control (0.762 [0.629–0.869]) and Before vs. After (0.716 [0.567–0.823]). Conclusions: Measurable changes in the exhaled volatilome were observed on postoperative day 10 following curative colorectal cancer surgery, with heterogeneous patterns across individual VOC features and persistent differences from healthy controls. These findings should be interpreted as early postoperative volatilome remodeling rather than as evidence of tumor-specific metabolic normalization because the observed changes may reflect the combined influence of surgical trauma, postoperative recovery, and other biological and perioperative processes. The identified 16-feature multivariable VOC signature should therefore be regarded as exploratory and requires independent external validation. Further studies incorporating larger multicenter cohorts, serial sampling beyond the early postoperative period, appropriate non-oncological surgical control groups, and orthogonal chemical identification are required to determine the potential clinical relevance of longitudinal VOC patterns.
Purpose of the study. To systematize the data of modern literature on pathohistological negative prognostic factors in locally advanced colorectal cancer and to determine their prognostic influence on the clinical course of the disease. Materials and methods. Scientific literature was searched using PubMed, Web of Science, eLibrary, and Google Scholar databases. The review includes original articles, systematic reviews, and meta-analyses of the last 10 years, which investigated the prognostic role of the pathohistological features of colorectal cancer. Results. The prognostic assessment for locally advanced colorectal cancer, based on the TNM classification, is characterized by limited accuracy, since it does not take into account some significant pathohistological features of the tumor lesion. Modern studies have demonstrated the effect of the presence of low tumor differentiation, lymphovascular invasion, perineural invasion, tumor budding, and extranodal extension in postoperative material on increasing the risk of disease recurrence. There is a need for their mandatory evaluation during pathomorphological examination with subsequent integration into the staging system. Verification of tumor deposits is a special prognostic predictor and correlates with a more aggressive course of the oncological process. It has been found that an increase in the number of tumor deposits has an unfavorable prognostic effect on overall and disease-free survival, regardless of the lesion of regional lymph nodes. The information obtained substantiates the expediency of a comprehensive analysis of the pathohistological features of the tumor process in risk stratification in patients with locally advanced colorectal cancer and the formation of individual treatment strategies.